SCHEMBL15833010

SCHEMBL15833010

C#C[C@@]1(F)C[C@@](F)(CO[PH](=O)Oc2ccccc2)O[C@H]1n1cnc2c(OCC)nc(N)nc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15833006 0.83 NT5E (0.30) —
SCHEMBL16647623 0.83 NT5E (0.34) —
SCHEMBL18475773 0.83 NT5E (0.34) —
SCHEMBL20754387 0.82 SLC29A1 (0.33) —
SCHEMBL17378467 0.81 ADORA2A (0.35) —
SCHEMBL18877202 0.80 ADORA2A (0.33) —
SCHEMBL18671934 0.79 ADORA2A (0.31) —
SCHEMBL16644377 0.79 ADORA2A (0.31) —
SCHEMBL21100305 0.78 PDE5A (0.31) —
SCHEMBL21100287 0.78 PDE5A (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014100505-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF ALIOS BIOPHARMA, INC. (US) 2014-06-26 — — WO disclosed
Send feedback